CN1772096A - Arrhythmia treating Chinese medicine composition - Google Patents
Arrhythmia treating Chinese medicine composition Download PDFInfo
- Publication number
- CN1772096A CN1772096A CN 200510017274 CN200510017274A CN1772096A CN 1772096 A CN1772096 A CN 1772096A CN 200510017274 CN200510017274 CN 200510017274 CN 200510017274 A CN200510017274 A CN 200510017274A CN 1772096 A CN1772096 A CN 1772096A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- medicine composition
- poria
- salviae miltiorrhizae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 206010003119 arrhythmia Diseases 0.000 title abstract description 7
- 230000006793 arrhythmia Effects 0.000 title abstract description 7
- 239000004863 Frankincense Substances 0.000 claims abstract description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 18
- 235000008434 ginseng Nutrition 0.000 claims abstract description 18
- 241000721047 Danaus plexippus Species 0.000 claims abstract description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 18
- 241000208340 Araliaceae Species 0.000 claims description 17
- 241000717739 Boswellia sacra Species 0.000 claims description 17
- 239000000470 constituent Substances 0.000 claims description 8
- 239000002671 adjuvant Substances 0.000 claims description 6
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 6
- 235000003717 Boswellia sacra Nutrition 0.000 abstract description 2
- 235000012035 Boswellia serrata Nutrition 0.000 abstract description 2
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 208000031971 Yin Deficiency Diseases 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 239000000843 powder Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 7
- 206010033557 Palpitations Diseases 0.000 description 6
- 238000004821 distillation Methods 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 206010013786 Dry skin Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 230000006837 decompression Effects 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 239000003390 Chinese drug Substances 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- 239000001116 FEMA 4028 Substances 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 2
- 229960004853 betadex Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- -1 filter Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 239000007909 solid dosage form Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041956 Stasis syndrome Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000005634 blind loop syndrome Diseases 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to one kind of arrhythmia treating Chinese medicine composition. The arrhythmia treating Chinese medicine composition has recipe comprising roasted licorice and ginseng as monarch component, red sage, rehmannia root, Tuckahoe and frankincense as minister component, and cassia twig and flavescent sophora root as assistant and guide component, in certain weight proportion. The Chinese medicine composition is used in treating arrhythmia and Qi-Yin deficiency with blood stasis and has high and determined curative effect.
Description
Technical field
The invention belongs to the field of Chinese medicines, relate to the ARR Chinese medicine composition of a kind of treatment.
Background technology
Arrhythmia belongs to traditional Chinese medical science cardiopalmus category.Just existing related symptoms record in " interior warp ".As " element ask three body parts and nine pulse-taking sites opinion ": " arrhythmia of pulse person disease, the irregularity in frequency of pulse beat person is dead at the middle part "; " element ask the most pure virginity will discuss greatly ": " violent palpitation ... sick this at the heart "; " element is asked a thorn malaria piece of writing ": " heart is feared so " etc.The special book treatise on Febrile Diseases of first determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs of the traditional Chinese medical science and " Medical Treasures of the Golden Chamber " are referred to as " severe palpitation ", " palpitation ", " throbbing with fear " in the heart and reach " palpitation with fear " etc., and think all factors such as void, water accumulating in middle-JIAO, " water is at kidney " of yang blood and qi intentionally.Along with the development of medical practice, more comprehensive to the understanding of cardiopalmus." concise exposition on febrile disease " proposes " deficiency of vital energy " and " stopping drink " is two big factors of cardiopalmus generation to propose " void then ... palpitation with fear, " as Thousand Golden Prescriptions, " danxi's experiential therapy " thinks that " blood deficiency, palpitation with fear sometimes ", Jing-Yue Complete Works think " allly control this person; should support vital QI can activate the production of essence, taste Baconic ".
Summary of the invention
The purpose of this invention is to provide the ARR Chinese medicine composition of a kind of treatment.
The ARR Chinese medicine composition of a kind of treatment of the present invention, according to monarch, minister, help, make and carry out prescription: Radix Glycyrrhizae Preparata, Radix Ginseng are monarch drug; Radix Salviae Miltiorrhizae, Radix Rehmanniae, Poria, Olibanum are ministerial drug; Ramulus Cinnamomi, Radix Sophorae Flavescentis are adjuvant altogether; And the constituent of this Chinese medicine composition and percentage by weight are: Radix Glycyrrhizae Preparata 17%-18%, Radix Ginseng 5.5%-6.5%, Radix Salviae Miltiorrhizae 17%-18%, Poria 17%-18%, Radix Rehmanniae 14.5%-15.5%, Ramulus Cinnamomi 2.5%-3.5%, Olibanum 5.5%-6.5%, Radix Sophorae Flavescentis 17%-18%.
Below, according to the Chinese medicine and pharmacy theory, the ARR Chinese medicine composition of a kind of treatment of the present invention is further illustrated:
Radix Glycyrrhizae Preparata is sweet in this Chinese medicine composition, and is flat, GUIXIN, lung, spleen, kidney channel.Qualcomm meridian, sharp vim and vigour, replenishing QI to invigorate the spleen, emergency nourishes heart.The Radix Ginseng nature and flavor are sweet, and little hardship is returned spleen, lung meridian.Strongly invigorating primordial QI, invigorating the spleen to benefit the lung, tranquilizing by nourishing the heart, promoting the production of body fluid to quench thirst has the reinforcing both QI and YIN magical effect.Two medicines mutually 5, supplementing QI and nourishing YIN is just to the card of deficiency of both QI and YIN; Simultaneously, Radix Glycyrrhizae Preparata qualcomm meridian, sharp vim and vigour effect are more conducive to treat the double stasis of blood, so be monarch drug.Poria is sweet, and is light, flat, GUIXIN, spleen, kidney channel.Open the breast internal organs, transfer visceral-qi, long cloudy, physical strength profiting, during guarantor god keeps, happy beneficial will; Radix Rehmanniae is sweet, and hardship is cold, GUIXIN, liver, kidney channel.Yin-nourishing and body fluid promoting removes arthralgia due to stagnation of blood; The Radix Salviae Miltiorrhizae hardship is slightly cold, GUIXIN, pericardium, Liver Channel.Blood circulation promoting and blood stasis dispelling, reinforcing the heart sedate, nourishing blood to tranquillize the mind; The Olibanum suffering, hardship, temperature, GUIXIN, liver, spleen channel.Blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain.Four medicines, 5 usefulness, benefiting qi and nourishing yin, dissipating blood stasis and clearing away heat, promoting the circulation of QI to relieve pain.The auxiliary monarch drug of Poria is strengthened the supplementing QI and nourishing YIN effect; The special YIN nourishing of Radix Rehmanniae merit with Radix Ginseng, Poria mutually 5, is strengthened the nourishing YIN and benefiting blood effect; The Radix Salviae Miltiorrhizae blood stasis dispelling, with Radix Ginseng mutually 5 and can nourishing blood to tranquillize the mind; The pain relieving of Olibanum regulating qi to disperse stagnation with Radix Glycyrrhizae Preparata, Radix Salviae Miltiorrhizae mutually 5, is beneficial to the blood stasis dispelling relieving spasm to stop pain.Become ministerial drug altogether.The Radix Sophorae Flavescentis hardship, cold, GUIXIN, liver, stomach, large intestine, urinary bladder channel.Heat clearing away, diuresis.Ramulus Cinnamomi suffering, sweet, warm, GUIXIN, lung, urinary bladder channel.Multiple arteries and veins activates yang.Ramulus Cinnamomi activating YANG with pungent and warm drugs, assistant Radix Glycyrrhizae are beneficial to the multiple arteries and veins of perfect square; The Radix Sophorae Flavescentis clearing away heat and promoting diuresis, the assistant Radix Glycyrrhizae is beneficial to the perfect square mind calming.Two medicines phase 5, the property that its hot warm-dryness syndrome is wet can prevent the greasy fraud of perfect square tonic taste again.Become adjuvant altogether.Last eight flavor medicines phases 5 embody supplementing QI and nourishing YIN, blood stasis dispelling mind calming effect.
The present invention has better curative effect for the arrhythmia deficiency of both QI and YIN blood stasis syndrome of holding concurrently.Clinical practice 60 examples, effective percentage 83.3%, obvious effective rate 43.33%.
A kind of preparation method for the treatment of ARR Chinese medicine composition of the present invention is, the people participated in frankincense powder be broken into fine powder, and is standby; The Radix Salviae Miltiorrhizae of proportional quantity adds ethanol extraction, filters, and filtrate is through being evaporated to the thick paste of relative density 1.30-1.35 (50 ℃), and 50 ℃ of dryings are ground into fine powder; The Ramulus Cinnamomi of proportional quantity is soaked, water vapour distillation volatile oil, and medicinal residues and distillation back water liquid are standby, volatile oil beta-cyclodextrin inclusion compound, sucking filtration, precipitate dry for standby; Radix Glycyrrhizae Preparata, Radix Rehmanniae, Poria, the Radix Sophorae Flavescentis of medicinal residues after the above-mentioned processing and proportional quantity are decocted with water, filter, water liquid after filtrate and the Rhizoma Zingiberis distillation merges, be evaporated to the clear paste of relative density 1.10-1.15 (25 ℃), precipitate with ethanol (making concentration of alcohol reach 70%-80%), stir, left standstill 24 hours, filter, decompression recycling ethanol also is concentrated into the thick paste of relative density 1.30-1.35 (50 ℃), adds above-mentioned fine powder, stir, 80 ℃ of dryings are ground into fine powder, promptly get Chinese medicine composition of the present invention with Radix Salviae Miltiorrhizae extractum powder and clathrate mix homogeneously.
The present invention can make any solid dosage forms with existing Chinese drug preparation technique and process, comprises capsule, tablet, powder or pill etc.
The specific embodiment
Embodiment 1: the ARR Chinese medicine composition of a kind of treatment of the present invention, and according to monarch, minister, help, make and carry out prescription: Radix Glycyrrhizae Preparata, Radix Ginseng are monarch drug; Radix Salviae Miltiorrhizae, Radix Rehmanniae, Poria, Olibanum are ministerial drug; Ramulus Cinnamomi, Radix Sophorae Flavescentis are adjuvant altogether; And the constituent of Chinese medicine composition and percentage by weight are: Radix Glycyrrhizae Preparata 17.6%, Radix Ginseng 6%, Radix Salviae Miltiorrhizae 17.6%, Poria 17.6%, Radix Rehmanniae 14.7%, Ramulus Cinnamomi 2.9%, Olibanum 6%, Radix Sophorae Flavescentis 17.6%.
Embodiment 2:
The ARR Chinese medicine composition of a kind of treatment of the present invention, according to monarch, minister, help, make and carry out prescription: Radix Glycyrrhizae Preparata, Radix Ginseng are monarch drug; Radix Salviae Miltiorrhizae, Radix Rehmanniae, Poria, Olibanum are ministerial drug; Ramulus Cinnamomi, Radix Sophorae Flavescentis are adjuvant altogether; And the constituent of Chinese medicine composition and percentage by weight are: Radix Glycyrrhizae Preparata 18%, Radix Ginseng 5.5%, Radix Salviae Miltiorrhizae 18%, Poria 18%, Radix Rehmanniae 14.5%, Ramulus Cinnamomi 2.5%, Olibanum 5.5%, Radix Sophorae Flavescentis 18%.
Embodiment 3:
The ARR Chinese medicine composition of a kind of treatment of the present invention, according to monarch, minister, help, make and carry out prescription: Radix Glycyrrhizae Preparata, Radix Ginseng are monarch drug; Radix Salviae Miltiorrhizae, Radix Rehmanniae, Poria, Olibanum are ministerial drug; Ramulus Cinnamomi, Radix Sophorae Flavescentis are adjuvant altogether; And the constituent of Chinese medicine composition and percentage by weight are: Radix Glycyrrhizae Preparata 17%, Radix Ginseng 6.5%, Radix Salviae Miltiorrhizae 17%, Poria 17%, Radix Rehmanniae 15.5%, Ramulus Cinnamomi 3.5%, Olibanum 6.5%, Radix Sophorae Flavescentis 17%.
Embodiment 4:
Present embodiment is a kind of preparation method for the treatment of ARR Chinese medicine composition: gets Radix Ginseng 100g (6%) and is ground into fine powder with Olibanum 100g (6%), and standby.Radix Salviae Miltiorrhizae 330g (17.6%) adds ethanol extraction, filters, and merging filtrate, decompression recycling ethanol also is concentrated into the thick paste of relative density 1.30-1.35 (50 ℃), and 50 ℃ of dryings are ground into fine powder.Ramulus Cinnamomi 55g (2.9%) soaks, water vapour distillation volatile oil, and medicinal residues and distillation back water liquid are standby.The volatile oil beta-cyclodextrin inclusion compound, sucking filtration, precipitate dry for standby.Radix Glycyrrhizae Preparata 330g (17.6%) with above-mentioned medicinal residues and proportional quantity, Radix Rehmanniae 275g (14.7%), Poria 330g (17.6%), Radix Sophorae Flavescentis 330g (17.6%) decocts with water, filter, filtrate and Ramulus Cinnamomi distillation back water liquid merge, be evaporated to the clear paste of relative density 1.10-1.15 (25 ℃), precipitate with ethanol (making concentration of alcohol reach 70%-80%), stir, left standstill 24 hours, filter, decompression recycling ethanol also is concentrated into the thick paste of relative density 1.30-1.35 (50 ℃), adds above-mentioned fine powder, stir, 80 ℃ of dryings are ground into fine powder, promptly get Chinese medicine composition of the present invention with Radix Salviae Miltiorrhizae extractum powder and clathrate mix homogeneously.Can make any solid dosage forms with existing Chinese drug preparation technique and process, comprise capsule, tablet, powder or pill etc.
Claims (4)
1. ARR Chinese medicine composition of treatment, according to monarch, minister, help, make and carry out prescription, it is characterized in that: Radix Glycyrrhizae Preparata, Radix Ginseng are monarch drug; Radix Salviae Miltiorrhizae, Radix Rehmanniae, Poria, Olibanum are ministerial drug; Ramulus Cinnamomi, Radix Sophorae Flavescentis are adjuvant altogether; And the constituent of Chinese medicine composition and percentage by weight are: Radix Glycyrrhizae Preparata 17%-18%, Radix Ginseng 5.5%-6.5%, Radix Salviae Miltiorrhizae 17%-18%, Poria 17%-18%, Radix Rehmanniae 14.5%-15.5%, Ramulus Cinnamomi 2.5%-3.5%, Olibanum 5.5%-6.5%, Radix Sophorae Flavescentis 17%-18%.
2. the ARR Chinese medicine composition of a kind of treatment according to claim 1, it is characterized in that: the constituent of this Chinese medicine composition and percentage by weight thereof are: Radix Glycyrrhizae Preparata 17%, 6%, Radix Ginseng 6%, Radix Salviae Miltiorrhizae 17.6%, Poria 17.6%, Radix Rehmanniae 14.7%, Ramulus Cinnamomi 2.9%, Olibanum 6%, Radix Sophorae Flavescentis 17.6%.
3. the ARR Chinese medicine composition of a kind of treatment according to claim 1, it is characterized in that: the constituent of this Chinese medicine composition and percentage by weight thereof are: Radix Glycyrrhizae Preparata 18%, Radix Ginseng 5.5%, Radix Salviae Miltiorrhizae 18%, Poria 18%, Radix Rehmanniae 14.5%, Ramulus Cinnamomi 2.5%, Olibanum 5.5%, Radix Sophorae Flavescentis 18%.
4. the ARR Chinese medicine composition of a kind of treatment according to claim 1, it is characterized in that: the constituent of this Chinese medicine composition and percentage by weight thereof are: Radix Glycyrrhizae Preparata 17%, Radix Ginseng 6.5%, Radix Salviae Miltiorrhizae 17%, Poria 17%, Radix Rehmanniae 15.5%, Ramulus Cinnamomi 3.5%, Olibanum 6.5%, Radix Sophorae Flavescentis 17%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100172742A CN100348232C (en) | 2005-11-09 | 2005-11-09 | Arrhythmia treating Chinese medicine composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100172742A CN100348232C (en) | 2005-11-09 | 2005-11-09 | Arrhythmia treating Chinese medicine composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1772096A true CN1772096A (en) | 2006-05-17 |
| CN100348232C CN100348232C (en) | 2007-11-14 |
Family
ID=36759347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100172742A Active CN100348232C (en) | 2005-11-09 | 2005-11-09 | Arrhythmia treating Chinese medicine composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100348232C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103705634A (en) * | 2014-01-04 | 2014-04-09 | 闫明昌 | Ninxin capsule |
| CN104127556A (en) * | 2014-08-14 | 2014-11-05 | 范恒银 | Traditional Chinese medicine (TCM) preparation for treating arrhythmia |
| CN104173915A (en) * | 2014-07-25 | 2014-12-03 | 吴伶 | Traditional Chinese medicinal composition for treating arrhythmia |
| CN104758587A (en) * | 2015-03-26 | 2015-07-08 | 赵世明 | Traditional Chinese medicine composition for treating arrhythmia |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1215600A (en) * | 1997-10-23 | 1999-05-05 | 黄付堂 | Oral liquid for treating heart disease |
| CN1349811A (en) * | 2000-10-19 | 2002-05-22 | 栾光斗 | Composite Chinese medicine for treating viral myocarditis |
| CN1209121C (en) * | 2001-04-29 | 2005-07-06 | 王运景 | Heart-strengthening and blood circulation-promoting liquid medicine for treating heart diseases |
| CN100358495C (en) * | 2003-05-20 | 2008-01-02 | 内蒙古伊泰医药科技开发有限责任公司 | Prepared licorice granule and its preparation method |
| CN1457857A (en) * | 2003-05-20 | 2003-11-26 | 濮桂宝 | Prepared licorice granular powder |
| CN1314429C (en) * | 2003-07-03 | 2007-05-09 | 郭俊京 | Chinese traditional medicine for treating cardiac arrhythmia and its preparation method |
| CN100490787C (en) * | 2003-12-26 | 2009-05-27 | 王保安 | Capsule for treating heart palpitation |
| CN1281268C (en) * | 2004-06-04 | 2006-10-25 | 华玉强 | Chinese medicinal composition for supplementing Qi, nourishing heart and calming mind and its preparation and identification |
| CN100479842C (en) * | 2004-12-01 | 2009-04-22 | 山东中医药大学附属医院 | Medicine for treating arrhythmia and preparation method thereof |
-
2005
- 2005-11-09 CN CNB2005100172742A patent/CN100348232C/en active Active
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103705634A (en) * | 2014-01-04 | 2014-04-09 | 闫明昌 | Ninxin capsule |
| CN104173915A (en) * | 2014-07-25 | 2014-12-03 | 吴伶 | Traditional Chinese medicinal composition for treating arrhythmia |
| CN104127556A (en) * | 2014-08-14 | 2014-11-05 | 范恒银 | Traditional Chinese medicine (TCM) preparation for treating arrhythmia |
| CN104127556B (en) * | 2014-08-14 | 2016-04-27 | 范恒银 | One treats ARR Chinese medicine preparation |
| CN104758587A (en) * | 2015-03-26 | 2015-07-08 | 赵世明 | Traditional Chinese medicine composition for treating arrhythmia |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100348232C (en) | 2007-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100348232C (en) | Arrhythmia treating Chinese medicine composition | |
| CN1294944C (en) | Chinese medicinal preparation for treating breast impediment | |
| CN103638451A (en) | Traditional Chinese medicine for treating chronic hepatitis and preparation method thereof | |
| WO2024099339A1 (en) | Traditional chinese medicine composition and use thereof | |
| CN102813814B (en) | Traditional Chinese medicine formula for treating hypotension | |
| CN1879783A (en) | A medicine for treating diabetes | |
| CN100515462C (en) | Chinese medicine for treating cardiovascular and cerebrovascular trrombus and preparing method | |
| CN102579633B (en) | Traditional Chinese medicine composition for curing vital energy deficiency type postpartum lochiorrhea and preparation method thereof | |
| CN1294961C (en) | Oral liquid for curing myocardial ischemia and process for preparing the same | |
| CN101549057A (en) | Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN100459990C (en) | Medicine for treating coronary heart disease and preparation method thereof | |
| CN102225132A (en) | Traditional Chinese medicine compound for treating hyperlipidaemia, cerebral arteriosclerosis and ischemic stroke and preparation method thereof | |
| CN103784690B (en) | One treats cardiopathic Chinese medicine composition | |
| CN1745835A (en) | Diabetes mellitus pill and prescription thereof | |
| TWI840312B (en) | A chinese medicinal composition and its application | |
| CN100348233C (en) | Preparation method of Chinese medicinal composition for treating allodromy | |
| CN103230475B (en) | One treats psoriatic medicine | |
| CN1247237C (en) | Medicinal composition for treating coronary disease and its preparation and application | |
| CN101953943A (en) | Traditional Chinese medicine for treating chronic aplastic anemia | |
| CN101979058B (en) | Chinese medicament for treating chronic nephritis | |
| CN101912584A (en) | Medicine for treating melancholia and preparation method thereof | |
| CN101890069A (en) | Medicament for preventing and treating gout and preparation process thereof | |
| CN1076622C (en) | Chinese medicine for curing nephritis | |
| CN1857535A (en) | Medicine for treating cerebral infraction and its preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20090109 Address after: No. 188 South friendship Street, Shijiazhuang Patentee after: Li Minghai Address before: No. 5625 Renmin Street, Jilin, Changchun Patentee before: CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES |
|
| ASS | Succession or assignment of patent right |
Owner name: LI MINGHAI Free format text: FORMER OWNER: CHANGCHUN INST. OF APPLIED CHEMISTRY, CHINESE ACADEMY OF SCIENCES Effective date: 20090109 |
|
| ASS | Succession or assignment of patent right |
Owner name: SHIJIAZHUANG HUAXIN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LI MINGHAI Effective date: 20111008 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20111008 Address after: 050091, friendship South Avenue, 188 West Bridge, Hebei, Shijiazhuang Patentee after: SHIJIAZHUANG HUAXIN PHARMACEUTICAL Co.,Ltd. Address before: 050091 friendship South Avenue, Shijiazhuang, No. 188 Patentee before: Li Minghai |
|
| DD01 | Delivery of document by public notice |
Addressee: Ma Haibo Document name: payment instructions |
|
| DD01 | Delivery of document by public notice |